Acquisition can be faster and lower-risk than a greenfield build — but med-tech M&A needs clinical and operational judgment, not just financial and legal due diligence. That is the layer Bayeux adds.
In a maturing regional market, acquisition or merger can be a faster, lower-risk, more capital-efficient route to a regional presence than building from scratch. But in a sector this technical and regulated, M&A requires more than financial and legal diligence — it requires the judgment to assess whether a facility is genuinely compliant or only apparently so, whether its approvals will survive scrutiny, and whether its lines can sustain the output the deal is premised on.
A technical assessment conducted by people who have built and operated facilities to the same standard the deal assumes.
Direct presence across Saudi Arabia, the UAE, Egypt and the wider GCC — plus relationships across hospitals, manufacturers and regulators — surfaces who is operating, at what scale and to what standard. We also identify the targets to avoid.
Diligence conducted from the inside by people who have built and operated facilities to the same standard — assessing the physical facility, production capability, quality system implementation and team competency against what the deal assumes.
The full regulatory portfolio reviewed for what it is actually worth — SFDA renewals and obligations, ISO surveillance scope, CE Mark and EU MDR status — and what investment will be required to maintain or expand it post-acquisition.
Value is realised in the integration, not the closing. Bayeux aligns quality systems, consolidates supplier relationships, manages regulatory transfers and rationalises production lines so the combined entity is compliant from day one.
JVs structured from an understanding of what each party actually contributes — technology, approvals, market relationships, capability, capital — and what each needs the structure to protect. Commercially durable and legally defensible across jurisdictions.
In med-tech, the deal is won in the diligence, not the closing.Mergers & Acquisitions · Med-Tech
Doctor-led, end-to-end development of medical device and pharmaceutical ventures across the GCC and Egypt. We don't just advise — we build.